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Methylmercury is a neurotoxin athigh exposures, and the developing fetus is particularly suscep-
tible. Because exposure to methyimercury is primarily through fish, concern has been expressed
that the consumption offish by pregnant women could adversely affect their fetuses. The refer-
ence dose formethyimercuryestablshedbythe U.S. Environmental ProtectionAgencywas based
on a benchmark analysis ofdata from a poisoning episode in Iraq in which mothers consumed
seed grain treated with methylimercuryduring pregnancy. However, exposures in this study were
short term and at much higher levels than those that result from fish consumption. In contrast,
theAgency for Toxic Substances and Disease Registry (ATSDR) based its proposed minimal risk
level on a no-obsrved-adverse-effec level (NOAEL) derived from neurologic testing ofchildren
in the Seychelles Islands, where fish is an important dietary staple. Because no adverse effects
from mercurywere seen in theSeychelles study, theATSDRconsideredthe meanexposure in the
study to be a NOAEL. However, a mean exposure may not be a good indicator of a no-effect
exposure level. To provide an alternative basis for deriving an appropriate human exposure level
from theSeychellesstudy, we conducted abendcmarkanalysis on these data. Ouranalysis indud-
ed responses from batteries ofneurologc tests applied to children at6, 19, 29, and 66 months of
age. Wealsoanalyzeddevelopmental milestones (age firstwalked and firsttalked). Weesplored a
number ofdose-response models, sets ofcovariates to indude in the models, and definitions of
backound response. Ouranalysis also involved modeling responses exprssed as both continuous
and quantal data. The most reliable analyse were considered to be represented by 144 calculated
lower statisticalbounds on the bemar dose (BMDLs; the lower statistical bound on maternal
mercury hair level corresponding to an increase of 0.1 in the probability of an adverse response)
derived from themodl.ing ofcontinuous responses. The averagevalue ofthe BMDL in these 144
anlyses was 25 ppm mercuy in matenal hair, with a range of 19 to 30 ppm. Key works: bench-
mark dose, child deelopment, ftl exposure, fish, mercury, methyimercury, neurologic develop-
ment, Seychelles. EnironHealtbPerspect108:257-263 (2000). [Online 3 February2000]
hapt//ehpnetl.niehs.nibgov/docs/2OOO/lO8p257-263cumpabstrac.thm1
Methylmercury is a neurotoxin that at high
exposures can cause microcephaly, cerebral
palsy, seizures, mental retardation, and death
(12). Several poisoning episodes have con-
firmed that the fetal brain is particularly sus-
ceptible to methylmercury. The most severe
effects were seen in Minamata and Niigata,
Japan (3), where children were born with
severe cerebral palsy in a population that
consumed seafood contaminated with
methylmercury from an industrial operation.
Because exposure to methylmercury is pri-
marily through the consumption of fish,
concern has been raised regarding the health
of children whose mothers consumed fish
during pregnancy.
A reference dose (RfD) for methylmer-
cury of0.1 pg/kg/day was established by the
U.S. Environmental Protection Agency (EPA)
(4). This RfD was based on a benchmark
analysis ofdata from astudy of81 Iraqi chil-
dren whose mothers consumed seed grain
treated with methylmercury as a fungicide
(5). In this study an Iraqi mother's peak hair
mercury concentration during pregnancy was
associated with her child's neurodevelopment
defined by the age at which the child first
walked, first talked, and by a score derived
from a neurologic examination. Although
this study provided insight into exposure
levels that can cause neurologic effects in the
developing fetus, it has several features that
maylimit its usefulness in determining adose
response for chronic environmental exposure
to methylmercury, such as might occur from
eating fish. The ages at which the Iraqi chil-
dren firstwalked or first talked were based on
family members' memories obtained at a
mean age of 19 months after delivery, and
were not known precisely. Even birth dates
were not recorded precisely but were estab-
lished in relation to religious holidays, sea-
sons, etc. There was limited information
available on the child's environment, which
could have influenced his or her neurologic
development. The measures ofeffect in the
study (late walking, late talking, and neuro-
logic score) were relatively nonspecific to
neurologic deficit and may not have been
sensitive to methylmercury. Perhaps most
important, the exposures in the Iraqi study
occurred at a high level for a limited period
oftime, and consequently were not typical of
lower level and often chronic exposures asso-
ciatedwith fish consumption.
In contrast to the EPA's use ofthe Iraqi
study, the Agency for Toxic Substances and
Disease Registry (ATSDR) (6) developed its
proposed minimum risk level (MRL) of0.3
pg/kg/day for methylmercury from the
Seychelles Child Development data (7,8).
The Seychelles study examined longitudinal-
ly the neurologic and psychologic responses
of708 children whose mothers consumed a
relatively large amount of fish during preg-
nancy (7,8). The children were given a range
of sensitive tests of neurologic and psycho-
logic development. Information was avail-
able on a number of health, social, and
demographic variables that could have been
associated with test performance. Most
important, exposures in this study were
through fish, which is the route of concern
in human populations. Because there was no
association between methylmercury exposure
and neurologic or psychologic outcomes,
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ATSDR investigators considered the mean
maternal hair concentration of 15.3 ppm
from the Seychelles group with the highest
exposure to be a no-observed-adverse-effect
level (NOAEL), and used that NOAEL as its
basis for deriving the MRL. In an alternative
derivation ofits MRL, ATSDR investigators
considered the mean maternal hair concen-
tration of6.8 ppm from the entire Seychelles
cohort at 66 months to be aNOAEL.
The NOAEL approach applied by the
ATSDR is the traditional method for deriv-
ing an exposure judged to be without appre-
ciable risk of noncancer health effects to
humans (e.g., an RfD or an MRL). This
approach is most appropriate for experimen-
tal studies in which animals are placed in a
few discrete dose groups. Determination ofa
NOAEL is more problematic in epidemio-
logic studies such as the Iraqi or Seychelles
studies, in which exposures do not assume a
few discrete values. When an effect is seen in
an epidemiologic study, a mean exposure has
often been assumed to be a lowest-observed-
adverse-effect level (LOAEL). However, the
analysis may have demonstrated only that an
effect occurred somewhere within the range
of exposures in the study-a range that
might span several orders of magnitude.
Similarly, when an effect is not seen in an
epidemiologic study, a mean exposure is
sometimes assumed to be a NOAEL, as was
the case in the use ofthe Seychelles study by
ATSDR investigators. However, the mean
exposure may not be a good indicator ofthe
no-effect exposure. For example, adding a
large number of individuals to the cohort
with very low exposures could dramatically
affect the mean exposure, but would add
little information on the appropriate value
foraNOAEL.
The benchmark approach applied to the
Iraqi data by EPA investigators provides an
alternative to the NOAEL in determining an
RfD (9-11). The benchmark dose (BMD) is
the dose that corresponds to a specified level
ofadditional response called the benchmark
response (BMR). The BMD is calculated by
fitting a mathematical dose-response model
to the data. A lower statistical confidence
bound on the BMD (BMDL) replaces the
NOAEL in the calculation of an RfD. In
addition to methylmercury, as documented
in the EPA Integrated Risk Information
Service (IRIS database) (12), the EPA has
used this approach to determine RfDs or
reference air concentrations for a number of
other chemicals.
The BMD method has several advantages
over the NOAEL method, including making
better use ofdose-response information and
reflecting sample size more appropriately
(9,11). When applied to epidemiologic data,
the BMD allows for consideration of the
dose response over the entire exposure range
rather than assuming that the mean exposure
is eitheraNOAELorLOAEL.
Another advantage ofthe BMD method
is that a BMDL can be calculated from
negative data (data in which no statistically
significant dose-related trend is present).
With negative data, the point estimate ofthe
dose-response trend may be positive (in the
direction ofan adverse effect), zero, or nega-
tive (in the direction of a beneficial effect),
although anydeviation from zero mayreflect
only random variation and not a real effect
of exposure. If the point estimate of the
trend is zero or negative, the point estimate
of the BMD will be infinite (undefined),
whereas ifthe point estimate ofthe trend is
positive, the point estimate ofthe BMD will
be finite. A statistical upper bound on the
BMD obtained from negative data will be
infinite; otherwise the datawould, by defini-
tion, not be negative. However, a BMDL
derived from negative data will be a finite
number as long as the data do not demon-
strate astatisticallysignificant negative trend.
When data are negative, it is possible that
there is no effect oftreatment, in which case
a BMDL reflects only the statistical con-
straints imposed by the experimental design.
However, a BMDL represents a conservative
(in the health-protective sense) value. Even
though the data were negative, exposure
could have caused a small undetected
increase in an adverse health effect. The
BMDL is a statistical bound that reflects the
potential size ofsuch an increase.
We present benchmark analyses of the
Seychelles data similar to those applied to
the Iraqi data by the EPA in the develop-
ment of the methylmercury RfD. These
analyses may provide a sounder scientific
basis for developing an RfD or MRL from
the Seychelles data than a NOAELestimated
from this study. In addition to the Seychelles
study, neurologic studies of children from
high fish-consuming populations have also
been conducted in New Zealand (13,14)
and the Faroe Islands (15). These studies
should also be considered when developing
an exposure advisory for methylmercury. A
benchmark analysis similar to ours from the
Seychelles data has been developed from the
NewZealand data (14).
The Seychelles Study
The Seychelles Child Development Study
(7,8,16,17) began in 1989 in the Republic of
Seychelles, an archipelago in the Indian
Ocean, to measure developmental outcomes
in children whose mothers consumed fish
containing methylmercury during their
pregnancy. More than 700 mother/infant
pairs were enrolled in the main study during
pregnancy. The children's prenatal mercury
exposure was assessed by measuring the con-
centration ofmercury in a segment ofmater-
nal hair representative of the hair formed
during pregnancy. At 6.5 months ofage, the
children were given a neurologic examina
tion, tests ofvisual recognition memory (18)
and visual attention (19), and the Denver
Developmental Screening Test - Revised (20).
The Bayley Scales of Infant Development
(21) were given at 19 months and again at 29
months. The ages atwhich achildfirstwalked
and first talked were also recorded. At 66
months ofage the children were given a bat-
tery of tests that measured cognitive ability
[McCarthy Scales of Children's Abilities
(22)], language ability [Preschool Language
Scale (23)], reading and arithmetic achieve-
ment [Woodcock-Johnson Achievement
Tests (24)], visual-spatial adeptness [Bender-
Gestalt Test (25)], and social behavior [Child
BehaviorChecklist (26)]. Covariables likelyto
be associatedwith a child's developmentwere
also assessed, including maternal intelligence
[Raven Standard Progressive Matrices (27)],
home environment [HOME (28)], parental
education, andothersshown inTable 1.
Mercury hair concentrations in maternal
hair ranged from 0.5 to 26.7 ppm, and aver-
aged 6.8 ppm. By contrast, hair mercury
concentrations in the U.S. are estimated to
average 0.5 ppm (4). No adverse outcomes
were associated with mercury exposure at
anyage in the Seychelles study.
Benchmark Methodology
Most of the measured end points in the
Seychelles studywere recorded as continuous
responses, and several dose-response models
were applied to these continuous end points.
In the k-power model (10), the mean test
score (or a transformation thereof) was
assumed to be oftheform
p(a) =+(a)+ K 0 +PI C, + .Ci + . Cm, [1]
where dis the average maternal hair mercury
level during pregnancy in milligrams per
kilogram, C1, ..., Cm are covariates that may
also be correlated with test scores, andP 2 0,
PO) ...Pm' and K> 1 are parameters to be
estimated. The negative sign was assumed
whenever smaller responses were considered
more adverse. We also assumed that the test
scores were normally distributed (possibly
after transformation) with a mean, p(a,
given by Equation 1 and a SD, a, that was
independent of all covariates, including the
hair mercury concentration. Inclusion ofthe
parameter, K, allowed a nonlinear dose
response. IfKis fixed at K= 1, the k-power
model is identical to that used in ordinary
multiple linear regression.
Iftest scores below a predetermined value,
x0, are considered abnormal, the probability
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ofan abnormal test score from a child with a
mercuryhair concentration ofdimglkg is
1a) = M[xO -g(ad)flI}, [2]
where Nis the standard normal cumulative
distribution function. The probability of an
abnormal test score in an unexposed child is
p0POO) = N{[XO - 1(O)]/a}. [3]
Similar formulas apply when larger scores
are more adverse (10). The BMD was
defined as the maternal mercury hair con-
centration that caused the probability of an
abnormal test score to increase by an
amount BMR; i.e., as the hair concentration
that satisfied
P(BMD) -p0 = BMR. [4]
Although it is not explicit in the notation,
whenever a single cutoff, x0, is used to define
an abnormal response, both p0 and BMD
will be dependent on the covariates.
Alternatively, instead ofspecifying the
cutoff, x0, for an abnormal response, it is
possible to specify the percentage of unex-
posed individuals who have an abnormal
response, i.e., specify p0. Ifp0 is specified
under the k-power model, the definition of
the BMD (4) is equivalent to defining the
BMD as the exposure that corresponds to a
given change (BMRC) in the mean response
normalized by the SD; i.e., as the exposure
that satisfies
[,(BMD) - m(0)]/c= BMRC [5]
(10). For given values for p0 and BMR used
in Equation 4 there is a corresponding value
for BMRC in Equation 5 so that Equations
4 and 5 are equivalent. For example, forp0 =
0.05 and BMR = 0.1, the corresponding
value for BMRC = 0.61. Unlike when x0 is
specified, when p0 is specified, the BMD
does not depend on the covariates (10). This
is obvious from the equivalent definition of
the BMD given by Equation 5.
In addition to the k-power model, two
other dose-response models were applied to
continuous data from the Seychelles study.
As previously noted, if the underlying data
are normally distributed with a common
SD, specification of a dose-response model,
p(a), for the mean response and specification
ofa dividing point, x0, between normal and
abnormal (or, alternatively, of a proportion,
p0, of unexposed subjects whose responses
are considered abnormal) determines the
probability, Pa), ofan adverse response as a
function of exposure. Alternatively, we can
specify x0 orp0 and a functional form for the
probability, P(a), ofan adverse response; this
determines the mean response, P(a), where
p(O) is a linear function ofthe covariates, as
in the k-power model. This approach allows
us to define a model for continuous data
that corresponds to a predetermined func-
tional form for the probability of an adverse
response, and consequently permits the same
mathematical dose-response model to be
applied to quantal and continuous data (10).
Table 1. Definitions of reduced (red) and expanded (exp) sets of covariates used in the benchmark
calculations.
Covariate
Sex
Birthweighta
Birth ordera
Breastfedb
Child's medical historyc
Maternal agea
Maternal smoking in pregnancyd
Maternal alcohol in pregnancyd
Maternal medical historye
Language spoken in home(home)f
Score from homevisitg
Raven group(caregiver10)h
Maternal education, leveli
Paternal education, level'
Family incomeJ
Gestation agea
Hollingshead socioeconomic scalek
Hearing/
Child's mercury levela
6 months
Red Exp
X X
X X
X X
X X
X X
X X
_ X
X
X X
X X
X
X X
X X
- X
- X
19 and 29
months
Red Exp
X X
X X
X X
X X
X X
X X
- X
_ X
X X
X X
X X
X
X X
X X
X
X
Firstwalked
ortalked
Red Exp
X X
X X
X
X
X X
X X
X
X
X
X X
X X
X
X X
_ X
X
X
66 months
Red Exp
X X
X X
X X
X X
X X
X X
X
X
X X
X X
X X
_ X
X X
X X
X X
IQ, intelligence quotient.
aModeled as a continuous variable. "0-1 month, 1-6 months, or > 6 months. CNegative, diagnosed intrauterine growth
retardation or head circumference < or > 2 SD from normal. dNo or yes. 0Reported hypertension requiring medication,
negative. 'Creole, other language. 9. 31, > 31-35, or > 35. hLow < 16, normal 16-28, or high > 28. 'primary education, sec-
ondary through trade school, or polytechnic through university. '500-1,500 [Seychelles rupee (SR)I; 1,501-3,000 SR;
3,0014,000 SR; or > 4,000 SR. kUnskilled < 19, semiskilled > 19-29, skilled > 29-39, or minor/major business/professional
>39. 1.25db,>25-35db,or>35db.
Two such dose-response models for the
mean response were applied to the Seychelles
data. One model was determined by the
Weibull model for quantal data,
'a) =p0 + (1-po){l
-exp[-(a)al]}, [6]
and one determined by the logistic model,
Pa) =po + (1 -po){l - 1/[1 + (0a)'K]1, [7]
where P . 0 and K. 1 are estimated para-
meters that have roughly the same interpre-
tation as the corresponding parameters in
the k-power model. As in the k-power
model, with these models, the BMD will be
a function ofthe covariates when x0 is speci-
fied, but notwhenp0 is specified.
Each ofthe three models for continuous
data (k-power, Weibull, and logistic) was
applied to the continuous responses from
Seychelles data both with p0 specified and
with x0 specified. In addition, a linear model
was applied. The linear model was defined
by fixing K= 1 in the k-power model. In
analyses in which p0 was specified, it was
fixed at 0.05, as suggested by the convention
of considering 95% of clinical responses in
healthy individuals to define the normal
range. In analyses in which x0 was specified,
it was fixed at 2 SDs (in the adverse direc-
tion) from the overall mean response.
For a few of the tests a child's response
was recorded as a quantal response (e.g.,
abnormal/normal), and the results from
these tests were modeled using the Weibull
(Equation 6) dose-response model for quan-
tal data. In addition, each ofthe continuous
responses was converted into a quantal
response byconsidering a response abnormal
if it was more than 2 SDs away (in the
adverse direction) from the mean response of
the entire cohort, and then analyzed using
the Weibull model. In these analyses the
BMD was defined in the same way as in the
analyses ofthe continuous responses, i.e., as
the mercury hair concentration that corre-
sponded to an increase in 0.1 in the proba-
bility of an abnormal response [Equation 4
with BMR = 0.1].
We conducted each analysis ofa contin-
uous response without covariates. In addi-
tion, analyses with po specified were also
conducted using both an expanded set and a
reduced set of covariates (Table 1). These
sets of covariates have essentially the same
definitions as those in the original analyses
(7,8,16,17). In all models for continuous
responses with p0 specified, the BMD, as
well as corresponding point estimate and
confidence limit, does not depend on the
covariates. Covariates were not included in
analyses of quantal responses or in analyses
of continuous responses in which x0 was
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specified because, in both ofthese cases, the
BMD would be different for different values
of the covariates; therefore, to calculate a
BMDL using covariates, values would have
to be specified for each of the covariates. As
in the original analyses, certain responses
were transformed to make them conform
more closely to a normal distribution, and
outliers were eliminated. Alogarithmic trans-
formation was applied to outcomes of age
first walked and first talked, and a negative
reciprocal transformation was applied to the
data on the Fagan attention outcome (18) at
6 months. The data from the psychomotor
index were highly skewed at both 19 and 29
months, and were only analyzed in quantal
form. An outlierwas defined as a responsefor
which the absolute value of the residual was
greater than 3 times the SD ofthe residuals.
Parameter estimates were obtained using
the maximum likelihood method, and statis-
tical confidence bounds (e.g., the BMDL)
were computed by the profile likelihood
method (29). The BMDL was defined con-
ventionally as the 95% statistical lower confi-
dence bound on the BMD. In the imple-
mentation ofthe profile likelihood method, a
model was first reparameterized so that the
BMD was included explicitly as a parameter
in place ofP. Next, values (maximum likeli-
hood estimates) of the parameters were
obtained so that the log-likelihood, L, ofthe
data obtained its largest possible value, Lo.
The maximum likelihood estimate of the
BMD could theoretically be infinite. The
BMDL was then determined as the smallest
value ofthe BMD that satisfied the equation,
{2[Lo - L(BMD)]}112 = 1.645, where 1.645 is
the 95th percentile of the standard normal
distribution, and L(BMD) is the function of
the BMD (only) obtained by fixing the value
of the BMD and maximizing the log-likeli-
hood with respect to the remaining parame-
ters. These calculations were made using
computer programs specifically designed for
performing benchmark calculations (30).
Results
Table 1 provides specific BMDLs obtained
from each neurologic test using the Weibull
model (applied to both continuous and
quantal responses) and the k-power model.
Table 2 provides averages and ranges of
BMDLs over all neurologic tests for each
type ofbenchmark analysis applied.
Figure 1 illustrates the calculation ofthe
BMDL for five continuous responses, based
on the k-power model, withpo specified and
using the full set of covariates. In this case
(usingpo = 0.05 and BMR = 0.1), an equiva-
lent definition ofthe BMD is the hair con-
centration that causes the mean response to
differ from the mean response of unexposed
individuals, relative to 6, by BMRC = 0.61
[Equation 5]. Each plotted point in Figure 1
represents a residual (measured response
minus the mean response predicted by the
model) with the mercury effect and the con-
stant term added back in [i.e., (residual) +PO
± (a)jK]. The solid line represents the esti-
mated mean response as a function of hair
mercury, PO ± (pia)cf. The dotted curve repre-
sents the statistical bounding mean dose
response associated with the BMDL (i.e., PO ± (P'a , where ,B', and K' are the values of
P and Kassociated with the calculation ofthe
BMDL). The dotted line may be used to
approximate BMDLs associated with other
values ofp0 and BMR by using the corre-
sponding value for BMRC. However, this
approach provides only an approximation
because ,', and K' may be slightly different
fordifferentvalues ofp0 and BMR. Values of
BMRC that correspond to some specific
values forp0 and BMRare shown in Table 3.
Equivalent BMRCs that correspond to other
values ofp0 and BMRmaybe obtained using
the formula BMRC = Nf1(1 -po) - N-'(1 -po
- BMR), where Nf1 is the inverse ofthe stan-
dard normal distribution function (10).
Discussion
The point estimates ofthe BMDs (data not
shown) were in many instances theoretically
infinite because many of the dose-response
trends, although nonsignificant, were in the
direction of a beneficial effect of mercury.
However, the BMDLs were all finite, and
their values reflect the potential magnitude
of any small effect of mercury that went
undetected in this study.
BMDLs obtained from continuous data
using the Weibull, logistic, and k-power
models were similar. Application of the lin-
ear model resulted in larger BMDLs (data
not shown) that were outside the range of
maternal hair levels observed in the study.
The inclusion of covariates had little effect
on the BMDLs. Likewise, BMDLs were sim-
ilar whether based on specification of the
background response, p0, or ofx0, the mag-
nitude of a response considered abnormal.
However, BMDLs based on quantal data
were consistently smaller than those based
on the corresponding continuous data. For
example, the BMDLs computed from 12
quantal responses using the Weibull distrib-
ution (Table 4) had a mean of22.0 ppm and
a range of 19.4-23.7 ppm, whereas the 12
BMDLs computed in like manner (Weibull
distribution, no covariates) from the corre-
sponding continuous data had a mean of
25.0 ppm and a range of 23.1-27.2 ppm.
One possible reason for this difference is that
collapsing a continuous data point into a
quantal (yes/no) response results in a loss of
information, which can cause confidence
intervals on the BMD to become wider (i.e.,
cause the BMDL to become smaller). For
this reason, we believe that a BMDL derived
from a continuous response is preferred over
one derived from a quantal end point
obtained bycollapsing the corresponding con-
tinuous response, provided the distributional
Table 2. Some BMDLs (parts per million mercury in maternal hair) obtained using the Weibull and
k-power models and listed by covariate.
Weibull k-Power
Po xob Quantal POa b
Model None Exp None None None Exp None
6 months
Deep tendon reflexes - - - 22.8 - - -
Limb tone - - - 20.9
Overall neurologic - - - 15.8 - - -
Fagan visual recognition memory 26.0 26.0 27.4 19.7 26.0 26.0 26.9
Fagan attention 25.7 25.9 27.0 23.7 25.5 25.6 26.4
19 months
Mental development index 23.7 23.4 26.0 22.6 24.3 24.1 25.6
Psychomotor index - - - 22.3 - - -
29 months
Mental development index 24.1 24.4 25.7 21.9 24.0 24.2 24.8
Psychomotor index - - - 22.5 - - -
66 months
Bender Gestalt errors 26.9 26.7 28.5 22.7 26.7 26.7 27.5
Child Behavior Checklist total 27.2 27.2 29.0 19.4 20.0 26.9 27.8
McCarthy general cognitive index 24.4 24.2 26.5 22.7 24.7 24.6 25.9
Preschool Language total score 25.2 25.1 26.8 22.7 24.7 24.7 25.5
Woodstock-Johnson
Applied problems 23.1 23.5 25.3 22.7 23.9 24.3 25.5
Letterword recognition 23.7 23.7 25.3 22.7 23.8 23.9 24.7
Developmental milestones
Age firstwalked unassisted 24.9 24.0 25.9 22.7 24.4 23.2 26.8
Age firsttalked 24.6 23.5 25.9 20.3 25.0 24.1 25.9
Exp, expanded.
&Abnormal defined as a response > 2 SDs in adverse direction from mean response of entire cohort. bAbnormal defined
so that 5% of responses are abnormal(po =0.05).
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assumption (e.g., normality) required for a
continuous analysis is satisfied. The 144
BMDLs derived from continuous data using
the Weibull, logistic, or k-power models
averaged 25.0 ppm with a range of
19.4-30.3 ppm (Table 4).
Several choices were necessary to calcu-
late our BMDLs, including how the back-
ground response was specified (e.g., thevalues
ofp0 or x0 selected), the value selected for
the benchmark risk (BMR), and the dose-
response model used. These decisions are
generic in the sense that they are largely unre-
lated to the type ofexposure, health response,
or quality of data. The Weibull dose-
response model was usedbythe EPAto deter-
mine the current RfD (4), and was also used
in a number ofbenchmark analyses listed in
the IRIS database (12). Our choice ofBMR
= 0.1 was used by the EPA to derive its RfD
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able. The first paper that discussed th
approach proposed using p0 = 0.001 (31
Generally speaking, smaller values ofp0 resu
inlarger BMDLs.
Except for the linear model, which prn
duced larger BMDLs, the dose-respons
models applied to continuous end poin
(Weibull, logistic, and k-power) all produce
comparable BMDLs. This was not surprisin
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because these dose responses arefairlysimilar.
However, it is possible for different dose-
response models to yield radically different
BMDLs. This is a problem, particularly
when the dose response is permitted to rise
very steeply in the low-dose range (i.e., to
haveunboundedlylargeslopes atincreasingly
small doses). Not only can this type of
dose-response model yield ridiculously low
BMDLs, the dose-response represented by
such a model is biologically implausible (10).
We avoided this problem in our models by
restricting the parameter, K to no less than
1.0. (Any value ofK< 1 produces an infinite
slope at zerodose.)
Kjellstrom et al. (13) administered
scholastic and psychologic tests to 237 6-
and7-year-old children in New Zealand and
correlated the results with the mercury con-
centration in their mothers' hair during
v U 1 zU L4
Maternal hairmercuryconcentration (ppm) BMIDL
5 12 16 20 24
Maternal hairmercuryconcentration (ppm) BMDL
Figure 1. Partial residuals of scores from selected tests based on
the k-power model, usingthe expanded setof covariates andp, =
0.05. (A) Fagan visual recognition test at 6 months. (B) Mental
development index at 19 months. (C) Mental development index at
29 months. (D) McCarthy general cognitive index at 66 months. (E)
The mean response predicted by the k-power model is shown
(solid curve) and the calculation ofthe BMDLis illustrated.
cu
Materm&I heirmerCUryConcentration(ppff) BML
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Table 3. Values of BMRC corresponding to certain
values forp, and BMR.
pO BMR BMRC
0.01 0.05 0.77
0.01 0.1 1.1
0.05 0.05 0.36
0.05 0.1 0.61
pregnancy. Crump et al. (14) performed
benchmark calculations on five end points
from this study by applying the k-power
model in the same manner as in the present
paper. The results ofthis analysis were high-
ly dependent on the test scores ofone child
whose mother had a hair mercury level of86
ppm during pregnancy, which was more
than 4 times the hair mercury level of any
other mother. When this child's scores were
included in the analysis, BMDLs ranged
from 17 to 24 ppm, which is similar to the
range of BMDLs determined in the present
study from the Seychelles data. Although the
scores of this child were not outliers, when
they were omitted the BMDLs ranged from
7.4 to 10 ppm.
Crump et al. (32) developed BMDLs
from the Iraqi study (5) by applying the
k-power and Weibull models to continuous
data on age firstwalked, age first talked, and
neurologic score. These calculations were
made for a range ofvalues ofpO and BMR.
Considering the analyses that were compara-
ble to those in the present study (po = 0.05
and BMR = 0.1), the BMDLs obtained
ranged from 54 to 152 ppm. This range was
consistent with the conclusion by Crump et
al. (32) based on other analyses of the Iraqi
data that there was no conclusive evidence of
a mercury effect in this study below a mater-
nal hair level of80 ppm. The maternal hair
level used in the present study was the peak
level during pregnancy, whereas the average
level during pregnancy was used in the
Seychelles and New Zealand studies.
BMDLs from the Iraqi study would have
been smaller if they had been based on the
average level.
To derive its RfD from the Iraqi study,
the EPA (4) defined an overall quantal mea-
sure ofneurologic health defined in terms of
whether a child was abnormal in any one of
three outcomes (firstwalked after 18 months
ofage, first talked after 24 months ofage, or
had ascore > 3 on a neurologic examination).
This combined response was grouped into
five dose groups according to the mothers'
peak mercury hair concentration during
pregnancy. A Weibull dose response applied
to these grouped data resulted in a BMDL of
11 ppm mercury in mothers' hair. There are
several potential reasons why this BMDL
was lower than the range of 54 to 152
obtained by Crump et al. (32). First, collaps-
ing continuous responses into quantal
Table 4. Summary of BMDLs (parts per million mercury in maternal hair) by BMD analysis method.
Definition
Type ofdata of abnormal Covariates Model No. Average Range
Continuous XOa None Weibull 12 26.6 25.3-29.0
Logistic 12 26.7 25.3-29.1
k-Power 12 26.1 24.7-27.8
pob None Weibull 12 25.0 23.1-27.2
Logistic 12 25.0 23.0-27.3
k-Power 12 24.4 20.0-26.7
Reduced Weibull 12 25.4 23.5-30.1
Logistic 12 25.4 23.3-30.3
k-Power 12 24.5 19.4-26.8
Expanded Weibull 12 24.8 23.4-27.2
Logistic 12 24.7 23.2-27.2
k-Power 12 24.9 23.2-26.9
Quantal None Weibull 17 21.6 15.8-23.7
aAbnormal defined as a response > 2 SDs in adverse direction from mean response of entire cohort. bAbnormal defined
so that 5% ofthe responses are abnormal (po = 0.05).
responses results in a loss ofinformation and
consequently generally produces wider statis-
tical confidence bounds. Second, combining
three outcomes to produce an overall res-
ponse resulted in a very liberal definition of
abnormal. Based on this definition, 19% of
the Iraqi children would be expected to be
abnormal, even without any prenatal mer-
cury exposure. In general, increasing the
background response (i.e., increasing po)
results in a lower BMD and BMDL. Third,
the EPA assigned the geometric average hair
level to each exposure group. Crump (33)
noted that, whereas grouping ofdata should
be avoided whenever possible, assigning an
arithmetic average exposure to grouped data
generally provides a more accurate assess-
ment ofrisk than using a geometric average.
Because an arithmetic average is always larg-
er than a geometric average, the use of an
arithmetic average exposure will generally
result in a larger BMD. Whatever the rea-
sons for the different BMDLs obtained by
the EPA (4) and Crump et al. (32), the limi-
tations in the Iraqi study suggest that this
studyprovides a less adequate basis for deriv-
ing an RfD for methylmercury than the
Seychelles study.
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